Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GPCRs: emerging targets for novel T cell immune checkpoint therapy.
Dickinson K, Yee EJ, Vigil I, Schulick RD, Zhu Y. Dickinson K, et al. Among authors: schulick rd. Cancer Immunol Immunother. 2024 Oct 3;73(12):253. doi: 10.1007/s00262-024-03801-7. Cancer Immunol Immunother. 2024. PMID: 39358616 Free PMC article. Review.
Atypical chemokine receptors: emerging therapeutic targets in cancer.
Torphy RJ, Yee EJ, Schulick RD, Zhu Y. Torphy RJ, et al. Among authors: schulick rd. Trends Pharmacol Sci. 2022 Dec;43(12):1085-1097. doi: 10.1016/j.tips.2022.09.009. Epub 2022 Oct 26. Trends Pharmacol Sci. 2022. PMID: 36307250 Free PMC article. Review.
Group XIV C-type lectins: emerging targets in tumor angiogenesis.
Yee EJ, Vigil I, Sun Y, Torphy RJ, Schulick RD, Zhu Y. Yee EJ, et al. Among authors: schulick rd. Angiogenesis. 2024 May;27(2):173-192. doi: 10.1007/s10456-024-09907-x. Epub 2024 Mar 12. Angiogenesis. 2024. PMID: 38468017 Free PMC article. Review.
Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent Chemotherapy.
Yee EJ, Torphy RJ, Thielen ON, Easwaran L, Franklin O, Sugawara T, Bartsch C, Garduno N, McCarter MM, Ahrendt SA, Schulick RD, Del Chiaro M. Yee EJ, et al. Among authors: schulick rd. Ann Surg Oncol. 2024 Sep;31(9):6127-6137. doi: 10.1245/s10434-024-15443-1. Epub 2024 May 23. Ann Surg Oncol. 2024. PMID: 38780693
Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review.
Yee EJ, Ziogas IA, Moris DP, Torphy RJ, Mungo B, Gleisner AL, Del Chiaro M, Schulick RD. Yee EJ, et al. Among authors: schulick rd. Ann Surg Oncol. 2024 Oct;31(10):6504-6513. doi: 10.1245/s10434-024-15567-4. Epub 2024 Jul 7. Ann Surg Oncol. 2024. PMID: 38972927 Review.
Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection.
Yee EJ, Torphy RJ, Myers EK, Meguid C, Franklin O, Sugawara T, Franco SR, Clark TJ, Mungo B, Ahrendt SA, Schulick RD, Del Chiaro M, McCarter MM. Yee EJ, et al. Among authors: schulick rd. Ann Surg Oncol. 2024 Nov;31(12):8340-8351. doi: 10.1245/s10434-024-15975-6. Epub 2024 Aug 9. Ann Surg Oncol. 2024. PMID: 39120842
Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study.
Khomiak A, Ghaffar S, Rodriguez Franco S, Ziogas IA, Yee EJ, Franklin O, Cumbler E, Chauhan A, McCarter MD, Gleisner AL, Ahrendt S, Del Chiaro M, Schulick RD, Mungo B. Khomiak A, et al. Among authors: schulick rd. Ann Surg Oncol. 2024 Dec;31(13):8549-8559. doi: 10.1245/s10434-024-16142-7. Epub 2024 Sep 5. Ann Surg Oncol. 2024. PMID: 39237827
[No title available]
[No authors listed] [No authors listed] PMID: 39287907
[No title available]
[No authors listed] [No authors listed] PMID: 39320399
323 results